{"pageContent": "Objectives: To report the 3-year follow-up of a Phase I study of magnetic resonance imaging (MRI)-guided transurethral ultrasound ablation (TULSA) in 30 men with localised prostate cancer. Favourable 12-month safety and ablation precision were previously described.", "metaData": {"source": "[Salvage treatments following prostate radiation therapy: role of the urologist]\nhttps://pubmed.ncbi.nlm.nih.gov/25175343/"}}